Ovarian Cancer Trial, Recruiting NCT05251883 Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT05251883
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are female and 18 years of age or older
  • You have been diagnosed with ovarian cancer, confirmed by both imaging scans and tissue testing (pathology)
  • You have not received any anti-cancer drug treatment before your surgery at Sun Yat Sen Memorial Hospital of Sun Yat-Sen University
  • You have had surgery for ovarian cancer and are receiving follow-up treatment afterwards
  • You are willing to take part, are able to follow the study requirements, and can complete all necessary steps for enrollment
  • You are willing to sign a consent form agreeing to the collection and use of your health data

Who may not be able to join:

  • You have already received other anti-cancer treatments or had tumor-related surgery before joining the trial
  • You have been diagnosed with a cancer in another part of your body (in addition to ovarian cancer)
  • You have a neurological, psychiatric, or mental health condition that is not well controlled (confirm with trial site)
  • You are unable or unwilling to cooperate with the study team or accurately describe your response to treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Huaiwu Lu, The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phone: +86 18688395806

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
1 December 2023

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progression-Free-Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov